UPDATE: Goldman Sachs Raises PT on Intuitive Surgical to $567

Goldman Sachs raises its price targe to $567 on Neutral-rated Intuitive Surgical

on higher EPS estimates. Goldman Sachs says, "We maintain our Neutral rating, as we think the stock reflects an appropriately bullish outlook, making the risk/reward balanced. We raise our sales numbers to reflect greater penetration in new surgical categories, but this is partially offset by lower margins (the company indicated no intention to pass the Healthcare Reform Medical Device tax onto customers, which we had previously forecast)." ISRG closed at $516.86 a share yesterday.